greeksoup/ stock research
Stock research / United States / GENB / Planned sales

Generate Biomedicines, Inc. planned insider sales

In the last twelve months insiders at Generate Biomedicines, Inc. filed 3 Form 144 notices of planned sales, 44,619 shares worth $721,366 at the time of filing, from 1 seller. The latest, filed 29 October 2026: Arnold Frances (director), 11,409 shares worth $184,733, planned for around 29 October 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
29 October 2026Arnold FrancesDirector11,409$184,73329 October 2026None on Form 4 yetFidelity Brokerage Services LLCRestricted Stock VestingForm 144
2 September 2026Arnold FrancesDirector32,210$520,6312 September 20261,000 shares from 1 September 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
1 September 2026Arnold FrancesDirector1,000$16,0021 September 2026None on Form 4 yetFidelity Brokerage Services LLCRestricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?